CME – CME Group Inc.

CME Group Inc. Monthly Stock Report – November 28, 2025

CME Group Inc., based in Chicago, Illinois, is a leading player in the Financial Data & Stock Exchanges industry within the Financial Services sector. Founded in 1898, the company operates global contract markets for trading futures and options on futures contracts. Their diverse product offerings are linked to interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals. With a comprehensive array of essential clearing house services, trade processing, risk mitigation, and market data services, CME Group caters to a wide client base that includes professional traders, financial institutions, corporations, and governments. This report provides a detailed overview of CME Group’s current stock performance, financial metrics, market sentiment, and recent developments, offering investors insights for making informed decisions.

52-Week Price Performance Analysis

The analysis of CME Group Inc.’s performance over the last 52 weeks indicates a predominantly bullish trend. Currently priced at $282.795, the stock is near its 52-week high of $290.79 and above its low of $224.62, reflecting an impressive appreciation of 23.28% over the year. The stock’s movement aligns with a general pattern of rising prices, illustrated by the ascending trendline marking consistent higher highs and higher lows throughout the last year.

Key technical indicators include:

• Support Level: Approximately $240, which has served as a price floor during pullbacks in February and September.
• Resistance Level: Around $280, where the price has struggled to break through, particularly noted in May and again in November.
• Moving Averages: The fifty-day moving average is recorded at $269.7934, suggesting the current price remains above this average, indicative of a bullish market sentiment.

The recent price action displays a strong tendency toward breaking the $280 resistance, driven by a positive crossover above the moving average. If this upward momentum can be sustained, CME may establish a new trading range beyond the $280 mark.

Financial Performance and Metrics

CME Group reported total revenue of approximately $6.39 billion, accompanied by an EBITDA of about $4.49 billion. These figures signify robust operational profitability, reflecting heightened demand in the financial data services segment.

Here’s a snapshot of key financial metrics:

• Shares Outstanding: 360,596,647
• Shares Held Short: 5,410,273 (0.015% of float)
• Current Price: $282.795
• Target High Price: $314.00
• Mean Target Price: Approximately $284.07

These performance metrics underscore CME Group’s strong revenue-generating capabilities and financial health. Additionally, the company announced a 9% increase in its quarterly dividend to $1.25 per share, demonstrating a commitment to shareholder returns.

Recent News and Developments

On November 28, 2025, CME Group experienced a significant outage due to a cooling issue at its CyrusOne data centers, causing a halt in trading across several markets–including foreign exchange, commodities, Treasuries, and equities–for over 11 hours. This incident raised concerns regarding the reliability of the company’s critical infrastructure, particularly as it occurred during a low-volume trading period following the U.S. Thanksgiving holiday. Despite this setback, CME Group’s stock showed relative stability, trading flat at $281.10, and indicating resilience with an 18.5% year-over-year gain.

Notable developments also include:

• Citigroup Upgrade: On September 25, 2025, Citigroup upgraded CME Group’s rating from “Neutral” to “Buy,” with an average one-year price target of $290.50, suggesting a potential upside of 9.86%.
• Legal Victory: In an earlier development, CME Group successfully won a class-action lawsuit on July 25, 2025, where a jury ruled in favor of CME against contract breaches by Class B shareholders, enhancing investor confidence.

Market Sentiment and Analyst Recommendations

Overall analyst sentiment regarding CME Group is cautiously optimistic. Current recommendations reflect a consensus to “hold,” with an average recommendation score of 2.67 based on 15 analyst opinions. While there is a recognition of potential market volatility, analysts believe the company is well-positioned for future growth.

Analyst Target Prices:

• Target High Price: $314.00
• Target Low Price: $201.00
• Mean Target Price: Approximately $284.07
• Median Price: $290.00

These price targets suggest a wide scope for future price movements, indicating that investors need to stay vigilant regarding market dynamics and economic conditions that could impact CME Group’s stock.

Conclusion

In summary, CME Group Inc. stands out as a solid investment opportunity within the Financial Services sector, displaying strong financial health and resilience amid recent challenges. With a current price nearing its yearly high, controlled short interest, and a strategic market position, investors are advised to consider a “hold” strategy for the time being. While the recent outage poses short-term concerns, the long-term outlook remains vibrant, bolstered by a favorable analyst rating, a robust dividend policy, and significant revenue generation capabilities.

Investors should remain informed and monitor market developments as CME Group seeks to navigate its operational challenges and capitalize on growth opportunities within the financial markets.

Metric	Value
Market Cap	$102.0b
Total Debt	$3.8b
Total Cash	$2.6b
Shares Outstanding	360.6m
Float Shares	359.0m